Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $88.8 million.

  • Maxcyte's Non-Current Assets rose 1734.15% to $88.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $307.4 million, marking a year-over-year decrease of 49.44%. This contributed to the annual value of $67.8 million for FY2024, which is 1318.39% down from last year.
  • According to the latest figures from Q3 2025, Maxcyte's Non-Current Assets is $88.8 million, which was up 1734.15% from $76.5 million recorded in Q2 2025.
  • In the past 5 years, Maxcyte's Non-Current Assets ranged from a high of $88.8 million in Q3 2025 and a low of $8.2 million during Q3 2021
  • Moreover, its 5-year median value for Non-Current Assets was $43.7 million (2023), whereas its average is $49.7 million.
  • In the last 5 years, Maxcyte's Non-Current Assets surged by 31860.72% in 2022 and then plummeted by 1318.39% in 2024.
  • Maxcyte's Non-Current Assets (Quarter) stood at $13.7 million in 2021, then soared by 151.23% to $34.4 million in 2022, then soared by 127.06% to $78.1 million in 2023, then dropped by 13.18% to $67.8 million in 2024, then surged by 31.05% to $88.8 million in 2025.
  • Its last three reported values are $88.8 million in Q3 2025, $76.5 million for Q2 2025, and $74.2 million during Q1 2025.